IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety

Table 2

Mean changes in primary and secondary parameters between baseline and week 12.

Parameters	IQP-VV-102 group; ()	Placebo group; ()	value
	Mean change (SD)	Mean change (SD)
Body weight (kg)	3.29 (2.30)	0.83 (2.00)	<0.001
Waist circumference (cm)	3.17 (2.55)	0.61 (2.23)	<0.001
Hip circumference (cm)	2.99 (2.04)	1.30 (2.22)	<0.001
Body fat content (kg)	2.14 (3.42)	0.56 (2.43)	0.001
Body fat content (%)	1.52 (3.85)	0.22 (2.46)	0.024